Early improvement of radiological signs of large-vessel inflammation in giant cell arteritis upon glucocorticoid treatment

Rheumatology (United Kingdom)

Volumn 52, Issue 7, 2013, Pages 1335-1336

  Prieto González, Sergio ^a   García Martínez, Ana ^a   Arguis, Pedro ^a   Cid, Maria C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

AORTITIS; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; LETTER; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VASCULITIS;

ADRENAL CORTEX HORMONES; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE;

EID: 84879801375     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket161     Document Type: Letter

References (11)

1. Hauenstein C, Reinhard M, Geiger J et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology 2012;51:1999-2003.
2. Fuchs M, Briel M, Daikeler T et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012;39: 344-53.
3. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71:1170-6.
4. Cid MC, Prieto-Gonzalez S, Arguis P et al. The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites. APMIS Suppl 2009;117(Suppl 127):10-20.
5. Basu N, Watts R, Bajema I et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010;69:1744-50.
6. Blockmans D, de Ceuninck L, Vanderschueren S et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55:131-7.
7. Agard C, Barrier JH, Dupas B et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008;59:670-6.
8. Achkar AA, Lie JT, Hunder GG et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
9. Visvanathan S, Rahman MU, Hoffman GS et al. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis-a prospective longitudinal study. Rheumatology 2011;50:2061-70.
10. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A et al. Outcome of aortic involvement in giant cell arteritis (GCA) after 1-year follow-up: prospective study in 35 patients using computed tompography angiography (CTA). Arthritis Rheum 2012;64(10 Suppl):S994-5.
11. Garcia-Martinez A, Hernandez-Rodriguez J, Arguis P et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008;59:422-30.